Soft Tissue Sarcoma Stocks List Ranked for 2024 |

Symbol	Grade	Name	% Change
MNPR	C	Monopar Therapeutics Inc.	1.98
IMMX	D	Immix Biopharma, Inc.	6.55
TCON	D	TRACON Pharmaceuticals, Inc.	-7.56
PYXS	D	Pyxis Oncology, Inc.	-9.52
SHPH	F	Shuttle Pharmaceuticals Holdings, Inc.	-1.25

Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic

Symbol	Grade	Name	Weight
IWC	B	iShares Microcap ETF	0.05
IWN	B	iShares Russell 2000 Value ETF	0.02
AVSC	B	Avantis U.S. Small Cap Equity ETF	0.02
EWX	D	SPDR S&P Emerging Markets Small Cap ETF	0.02
DFEM	D	Dimensional Emerging Markets Core Equity 2 ETF	0.01

Compare ETFs

Compare EWX to DFEM Compare IWC to AVSC Compare IWC to IWN

Date	Stock	Title
Nov 21	PYXS	Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
Nov 21	PYXS	Pyxis stock craters 46% amid Phase 1 data, William Blair downgrade
Nov 20	PYXS	Pyxis Oncology plummets 38% on preliminary phase 1 data for cancer asset
Nov 20	PYXS	Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data

Soft Tissue Sarcoma: A soft-tissue sarcoma (STS) is a malignant tumour, a type of cancer, that develops in soft tissue. A soft tissue sarcoma is often a painless mass that grows slowly over months or years. They may be superficial or deep-seated. Any such unexplained mass will need to be diagnosed by biopsy. Treatment may include, surgery, radiotherapy, chemotherapy, and targeted drug therapy. The other type of sarcoma is a bone sarcoma.
There are many types. The World Health Organization lists more than fifty subtypes.